Persistence of IgG4 as a potential serological marker of disease activity in patients with epidermolysis bullosa acquisita treated with rituximab.
J O GordilhoD MiyamotoC W MarutaR M SantoA MahmoudT Navarro-RodriguezA L Werneck-SilvaL M de AguiarI C BorgesC G SantiValeria AokiPublished in: Journal of the European Academy of Dermatology and Venereology : JEADV (2023)